Skip to content

Texas · Nonprofit

YOUNG BLACK PHARMA

YOUNG BLACK PHARMA (Texas) receives grants from 1 organization whose IRS filings report $77,500 to it, the largest being PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA ($77,500). 1 of them have funded it in more than one year.

Revenue FY2025
$618k
Funders on record
1
Grants received
$78k
Net assets
$379k
1/1 repeat funderspeak grant-dependency 29%
01What it does

What Young Black Pharma does

Mission

Young Black Pharma's mission is to cultivate talent through mentoring initiatives that focus on the personal and professional development needed to excel in the pharmaceutical industry, inspire pharmaceutical industry professionals to always strive for excellence and prioritize paying it forward, and connect to share meaningful experiences and encourage community among people in pharma.

As stated on its FY2025 Form 990.

Programs

  1. Young Black Pharma Conference & Gala impacts in excess of 650 people providing professionally enriching and educational sessions on topics such as showing up as your authentic self at work, compensation negotiation, diversity in clinical trials, and building your leadership brand with expert speakers on these topics.

  2. PhRMA Graduate Summit Partner - 40 people impacted-provided tools and tips on how to approach pursuing a job in the pharmaceutical industry and how to prepare yourself from resume building to interviewing strategies.

  3. Professional Development Webinar Series - monthly virtual webinars covering various professional development topic with guest speakers and experts in the industry impacting hundreds of attendees throughout the year.

  4. Regional and Conference Networking Events - 300-500 people impacted-offered networking opportunities across the country with access to professionals from all different backgrounds and companies.

The 4 programs described on its FY2025 Form 990, listed largest first by expense. Program spending in total: $0.

02The organization over time

The organization over time

Each line starts at 100 in 2022, so what you read is the shape rather than the size: 150 means half as much again as 2022, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20222022 Revenue 100 ($70k) Expenses 100 ($49k) Net assets 100 ($21k)2023 Revenue 555 ($389k) Expenses 497 ($244k) Net assets 807 ($165k)2024 Revenue 1252 ($877k) Expenses 1212 ($595k) Net assets 2185 ($448k)2025 Revenue 882 ($618k) Expenses 1399 ($687k) Net assets 1850 ($379k)
2022202320242025
Revenue (882)Expenses (1399)Net assets (1850)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $172k to $507k (+195%).

$24k
$172k
$507k
$379k
2022202320242025
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2022
2023
2024
2025
ContributionsProgram revenueInvestmentOther

4% of YOUNG BLACK PHARMA’s revenue is contributions — more earned-revenue than three-quarters of its peers (62% for the typical peer).

This organization
Typical peer · 12,439 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 1 of the last 4 reported years ran a deficit.

$21k
’22
$145k
’23
$283k
’24
−$69k
’25
6.6
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

20242025
Listed44
Joined·+0
No longer listed·0
03Who funds it

Who funds it, year by year

2022 → 2023: the base held at 1 funder, grant income rose $20k → $25k.

Funder
'22
'23
'24*
total
funders
1
1
1

From the IRS filings of YOUNG BLACK PHARMA’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

Where its funders are

YOUNG BLACK PHARMA draws 100% of its grant income from funders outside Texas, across 1 state in all.

DC

In-state vs out-of-state, by year

’22
’23
Texas out of state home

Funder states come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

YOUNG BLACK PHARMA has grown faster than three-quarters of the 7,175 community improvement nonprofits its size.

Operating margin−11% · bottom quartile
Months of reserve6.6mo · below the median
Revenue growth (annualized)107% · top quartile

this organization peer median middle 50% of peers· 7,175 community improvement nonprofits $100k–$1M, FY2025

Organizations like YOUNG BLACK PHARMA

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Texas

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Governance

4
board members
100%
independent
–Conflict-of-interest policy–Whistleblower policy–Document retention✓Board reviewed the 990–Audited financials

Screen this organization

A dated, signed PDF of the compliance screen for YOUNG BLACK PHARMA: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds YOUNG BLACK PHARMA?
YOUNG BLACK PHARMA (Texas) receives grants from 1 organization whose IRS filings report $77,500 to it, the largest being PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA ($77,500). 1 of them have funded it in more than one year.
How many funders does YOUNG BLACK PHARMA have?
IRS filings report 1 organization giving $77,500 in grants to YOUNG BLACK PHARMA, 1 of which have funded it in more than one year.
Who is the largest funder of YOUNG BLACK PHARMA?
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA is the largest funder on record, with $77,500 in grants. The full list of funders is on this page.
How can an organization like YOUNG BLACK PHARMA find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Texas. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

Play a game about who funds Young Black Pharma →

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2022–2025), and the filings of 1 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing